Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
61	[JP] Enhanced umbilical cord adherent stem cells, method for producing and uses thereof (Registration number 06648259)
60	[US] Postnatal adherent cells and preparation method therefor (Registration number 10479978)
59	[KR] Isolation of lung cancer cells and proliferation thereof using suspension culture method (Registration number 10-2043603)
58	[KR] A method for preserving of Nuclear Transfer Cells and banking system thereof (Registration number 10-2035075)
57	[KR] Enhanced postnatal adherent cells and use thereof (Registration number 10-2011634)
56	[KR] Method for subculture of human single pluripotent stem cell and method for preparing transformed human pluripotent stem cell using the same (Registration number 10-1972766)
55	[KR] Methods and systems for harvesting cells (Registration number 10-1910685)
54	[KR] Method and composition for proliferating of natural killer cell (Registration number 10-1909879)
53	[CA] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 002802661)
52	[KR] Method for the Isolation and Proliferation of Primary Lung Cancer Cells (Registration number 10-1832133)